CTRI/2022/06/043488尚未招募未知
Evaluation of irritation potential of Skin care formulation on healthy human subjects having varied skin type
Kama Ayurveda Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1) Healthy Human Subjects
- •2) Skin should be healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scarâ?¦.).
- •3) Subjects willing to come for regular follow up and ready to follow instructions during the study period.
- •4) Subjects representing varied skin types (ideally equal representation of all 4 skin types â?? Oily, Normal, Dry and Combination)
排除标准
- •1For female: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months
- •2Having refused to give his/her assent by not signing the consent form
- •3Taking part in another study liable to interfere with this study
- •4Being diabetic.
- •5Being asthmatic.
- •6Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, antihistamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
- •7Having cutaneous hypersensitivity (except in the case of studies with evaluation of sensitive skin).
- •8Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
- •9Having undergone a surgery requiring a general anaesthesia of more than one hour in the past 6 months.
- •10Having changed his/her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit.
- •11The day of the patch application: no cosmetic product must be used (test site clean with water only). Refusing to follow the restrictions below during the study: - For female: Do not become pregnant nor breastfeed. - Do not take part in another study liable to interfere with this study - Do not take medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, and antihistamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol). - Do not change his/her cosmetic habits apart from the particular conditions mentioned in the protocol, on the studied anatomic unit
- •12Having eczema, psoriasis, lichen plan, vitiligo whatever the considered area
- •13Having disorder of the healing (whatever the considered area) • Having a rhinitis, allergic conjunctivitis, or rhino sinusitis
- •14Having an allergy to perfumes and/or conservatives in cosmetic products
- •15Having an allergy to plaster
- •16Having a food allergy
- •17Having a cardiovascular pathology (taking a beta blocker treatment)
- •18Having immunosuppressive drugs, such as cyclophosphamide, methotrexate, azathioprine, etc.
- •19Taking a retinoid-based treatment by general or oral route
- •20Taking specific treatment on the back.
- •21Having taken an anti-histaminic treatment in the last 2 weeks preceding the start of the study
- •22Having miliaria (prickly heat) on the back.
- •23Presenting too many naevus on the back
- •24Having high pilosity on the back.
- •25Refusing to follow the restrictions below during the study: - During the first 24 hours (after patch application), neither cosmetic products nor water must be applied on the back. - Till the follow up period of until T8 days, only water is accepted from the first reading i.e., T2 days (24 hours after the patch removal). - Do not practice an intensive sport activity during the first 24 hours (until the removal of the patches) - Do not expose the back to the sun.
研究者
相似试验
尚未招募
不适用
Evaluation of safety of Cosmetic ProductCTRI/2022/07/044412Kama Ayurveda Pvt Ltd
已完成
不适用
Safety test of cosmetic ProductCTRI/2023/01/049229Kama Ayurveda Pvt Ltd25
尚未招募
不适用
Safety assessment of Cosmetic ProductCTRI/2022/06/043384Kama Ayurveda Pvt Ltd
尚未招募
不适用
To check the Safety of cosmetic ProductsCTRI/2022/12/048012Kama Ayurveda Pvt Ltd
尚未招募
不适用
Safety assessment of Cosmetic ProductCTRI/2022/08/044955SkinQ